• COVID-19 mRNA Vaccine COMIRNATY®
  • Mode of action of mRNA
  • SARS-CoV-2
  • The second vaccination
  • From development to approval
  • For more information
  • Reporting side effects
  • Digital package leaflet
    • Deutsch
    • English
    • Español
    • Français
    • Italiano
    • Kurdî (Kurmancî)
    • Русский
    • Polski
    • Türkçe
    • Ελληνικά
    • Български
    • Hrvatski
    • Українська

    This website gives information about your vaccination.

    Please choose your language:

    Deutsch
    -
    English
    -
    Español
    -
    Français
    -
    Italiano
    -
    Kurdî (Kurmancî)
    -
    Русский
    -
    Polski
    -
    Türkçe
    -
    Ελληνικά
    -
    Български
    -
    Hrvatski
    -
    Українська
    -

    BioNTech Europe GmbH
    An der Goldgrube 12
    55131 Mainz / Deutschland

    T.: +49 6131 9084-0
    F: +49 6131 9084-2121
    M: service@biontech.de
    W: service.biontech.de

    Our vision: We aspire to utilize the full potential of the immune system to fight cancer and infectious diseases.

    Company
    Our DNA How we translate Science Connect Investors & Media Careers
    Resources
    Report a side effect Subscribe to our info service
    Terms of Use General Terms and Conditions General Conditions of Purchase Data Privacy Statement Data Processing Terms for Business Partners Imprint

    © Copyright BioNTech Europe 2022. All Rights Reserved.

    BNTCom00498

    Cookie–Settings